Trials / Recruiting
RecruitingNCT05502133
Identification of Acute Intermittent Porphyria Modifying Genes
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Icahn School of Medicine at Mount Sinai · Academic / Other
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
This study proposes to identify the predisposing/protective modifying genes that underlie the acute attacks in symptomatic patients with Acute Intermittent Porphyria (AIP), an autosomal dominant inborn error of heme biosynthesis.
Conditions
Timeline
- Start date
- 2022-09-23
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
- First posted
- 2022-08-16
- Last updated
- 2025-08-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05502133. Inclusion in this directory is not an endorsement.